eHealth vs Ethos Technologies
EHTH and LIFE side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EHTH and LIFE compare
Ethos Technologies is the larger company, worth 152 times as much as eHealth ($2.1B against $14.1M).
eHealth keeps more of each dollar of sales as profit, with a net margin of 4.9% compared with −16.2% at Ethos Technologies.
eHealth scores higher on the StockData Score (8 against 4 for Ethos Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EHTH | LIFE |
|---|---|---|
| Size and price | ||
| Market cap | $14.1M | $2.1B |
| Share price | $0.440 | $33.52 |
| Change, 1 year | −89.4% | 1664% |
| Change, 5 years | −98.2% | – |
| Beta (5Y) | 1.60 | 4.79 |
| Employees | 1,665 | 614 |
| StockData Score | ||
| Total score | 8 (better) | 4 |
| Valuation score | 2 | 2 |
| Growth score | 2 (better) | 1 |
| Performance score | 2 (better) | 0 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.0× (better) | 2.9× |
| P/B | 0.0× (better) | 4.2× |
| EV/EBITDA | 0.8× | – |
| P/FCF | – | 19.3× |
| FCF yield | −122% | 5.2% (better) |
| Growth | ||
| Revenue growth (TTM) | −13.6% | – |
| Revenue growth, 5Y average | −1.0% | – |
| Net income growth (TTM) | −54.4% | – |
| EPS growth (TTM) | −955% | – |
| Profitability | ||
| Gross margin | 44.7% | 98.1% (better) |
| Operating margin | 10.6% (better) | −16.1% |
| Net margin | 4.9% (better) | −16.2% |
| FCF margin | −3.7% | 15.2% (better) |
| Return on equity | 4.6% (better) | −58.1% |
| Return on invested capital | 6.2% (better) | −230% |
| Financial health | ||
| Debt / equity | 0.23 | – |
| Net debt / EBITDA | 0.55 | – |
| Interest coverage | 3.2× | – |
| Current ratio | 8.68 (better) | 1.47 |
| Altman Z-score | 0.85 | 4.52 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 56.9% | 27.7% |
| Held by insiders | 11.7% | 74.6% |
| Insider net buying, 12 months | $188K (better) | −$89.6M |
| Short interest, % of float | 2.8% | 22.7% |
Go deeper
- EHTH stock overview
- EHTH income statement
- EHTH valuation and score
- LIFE stock overview
- LIFE income statement
- LIFE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.